Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-04-01

AUTHORS

GJ Timmers, S Zweegman, AM Simoons-Smit, AC van Loenen, D Touw, PC Huijgens

ABSTRACT

We conducted an open label, randomised clinical trial to compare amphotericin B colloidal dispersion (ABCD, Amphocil) 2 mg/kg/day intravenously with fluconazole 200 mg/day orally, for the prevention of fungal disease in neutropenic patients with haematological malignancies. In the event of unresolved fever after 4 days of empirical antibacterial therapy, patients in both treatment groups were to receive ABCD, 4 mg/kg/day. However, the study had to be stopped in an early phase, due to severe side-effects of ABCD. A total of 24 patients were enrolled, 12 patients were randomly assigned to receive prophylactic ABCD, which was administered for a mean of 13.9 days. Fluconazole prophylaxis was given to 12 patients for a mean of 21.2 days. Therapeutic ABCD, 4 mg/kg, was initiated in four patients because of suspected fungal infection, all of whom had initially received fluconazole. A high rate of infusion-related toxicity of ABCD was observed. Chills occurred in 15/16 ABCD recipients (94%), accompanied by a temperature rise of ⩾2°C in 4/16 patients and of ⩾1°C but <2°c in 10/16 patients. Other abcd-related adverse events were hypotension (4/16), nausea with vomiting (5/16), tachycardia (7/16), headache (3/16) and dyspnoea (3/16). For premedication patients received: antihistamines (12/16), hydrocortisone (9/16) and/or morphine (6/16). ABCD was discontinued in 8/16 patients (50%) due to side-effects, which ultimately dictated early termination of the study. we conclude that ABCD is not suitable for antifungal prophylaxis in neutropenic patients due to severe infusion-related side-effects. Subject numbers were too low for conclusions on variables of antifungal efficacy. Bone Marrow Transplantation(2000) 25 , 879–884. More... »

PAGES

879-884

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1702243

DOI

http://dx.doi.org/10.1038/sj.bmt.1702243

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009839299

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10808210


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amphotericin B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bilirubin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Consumer Product Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Contraindications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluconazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morphine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mycoses", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neutropenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Tract Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Shivering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transaminases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Timmers", 
        "givenName": "GJ", 
        "id": "sg:person.016464171734.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016464171734.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zweegman", 
        "givenName": "S", 
        "id": "sg:person.01110171530.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110171530.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Microbiology and Infection Control, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Microbiology and Infection Control, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Simoons-Smit", 
        "givenName": "AM", 
        "id": "sg:person.014426711334.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014426711334.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Loenen", 
        "givenName": "AC", 
        "id": "sg:person.0621051006.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621051006.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Touw", 
        "givenName": "D", 
        "id": "sg:person.07531170642.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531170642.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huijgens", 
        "givenName": "PC", 
        "id": "sg:person.0643774744.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643774744.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1701406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022800093", 
          "https://doi.org/10.1038/sj.bmt.1701406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02112616", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046675262", 
          "https://doi.org/10.1007/bf02112616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024783933", 
          "https://doi.org/10.1038/sj.bmt.1701630"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01967060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001105921", 
          "https://doi.org/10.1007/bf01967060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01575124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046063617", 
          "https://doi.org/10.1007/bf01575124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024930306", 
          "https://doi.org/10.1038/sj.bmt.1701543"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-04-01", 
    "datePublishedReg": "2000-04-01", 
    "description": "We conducted an open label, randomised clinical trial to compare amphotericin B colloidal dispersion (ABCD, Amphocil) 2\u2009mg/kg/day intravenously with fluconazole 200\u2009mg/day orally, for the prevention of fungal disease in neutropenic patients with haematological malignancies. In the event of unresolved fever after 4 days of empirical antibacterial therapy, patients in both treatment groups were to receive ABCD, 4\u2009mg/kg/day. However, the study had to be stopped in an early phase, due to severe side-effects of ABCD. A total of 24 patients were enrolled, 12 patients were randomly assigned to receive prophylactic ABCD, which was administered for a mean of 13.9 days. Fluconazole prophylaxis was given to 12 patients for a mean of 21.2 days. Therapeutic ABCD, 4\u2009mg/kg, was initiated in four patients because of suspected fungal infection, all of whom had initially received fluconazole. A high rate of infusion-related toxicity of ABCD was observed. Chills occurred in 15/16 ABCD recipients (94%), accompanied by a temperature rise of \u2a7e2\u00b0C in 4/16 patients and of \u2a7e1\u00b0C but <2\u00b0c in 10/16 patients. Other abcd-related adverse events were hypotension (4/16), nausea with vomiting (5/16), tachycardia (7/16), headache (3/16) and dyspnoea (3/16). For premedication patients received: antihistamines (12/16), hydrocortisone (9/16) and/or morphine (6/16). ABCD was discontinued in 8/16 patients (50%) due to side-effects, which ultimately dictated early termination of the study. we conclude that ABCD is not suitable for antifungal prophylaxis in neutropenic patients due to severe infusion-related side-effects. Subject numbers were too low for conclusions on variables of antifungal efficacy. Bone Marrow Transplantation(2000) 25 , 879\u2013884.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1702243", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "neutropenic patients", 
      "clinical trials", 
      "fungal infections", 
      "amphotericin B colloidal dispersion", 
      "empirical antibacterial therapy", 
      "infusion-related toxicity", 
      "open label", 
      "unresolved fever", 
      "antifungal prophylaxis", 
      "fluconazole prophylaxis", 
      "adverse events", 
      "haematological malignancies", 
      "treatment groups", 
      "patients", 
      "bone marrow", 
      "antibacterial therapy", 
      "subject numbers", 
      "prophylaxis", 
      "high rate", 
      "infection", 
      "early phase", 
      "trials", 
      "fluconazole", 
      "days", 
      "prevention", 
      "early termination", 
      "antifungal efficacy", 
      "hypotension", 
      "nausea", 
      "vomiting", 
      "tachycardia", 
      "headache", 
      "antihistamines", 
      "fever", 
      "morphine", 
      "malignancy", 
      "therapy", 
      "fungal diseases", 
      "marrow", 
      "disease", 
      "recipients", 
      "efficacy", 
      "ABCD", 
      "total", 
      "chills", 
      "study", 
      "toxicity", 
      "events", 
      "conclusion", 
      "group", 
      "termination", 
      "rate", 
      "data", 
      "means", 
      "variables", 
      "number", 
      "rise", 
      "labels", 
      "phase", 
      "colloidal dispersions", 
      "dispersion", 
      "temperature rise"
    ], 
    "name": "Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial", 
    "pagination": "879-884", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009839299"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1702243"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10808210"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1702243", 
      "https://app.dimensions.ai/details/publication/pub.1009839299"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_335.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1702243"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702243'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702243'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702243'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702243'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      116 URIs      102 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1702243 schema:about N04964102cae44680b9ead4b7d1b24f50
2 N18335a9e5d9a48969e663cd07228dd61
3 N25401bfe614d4502b8d174d2908b0556
4 N398d7edf3e7f445dbbe17725dacb676b
5 N45507437099340988e93bdbd04eb99ff
6 N53b5c127328946e4aea0978026f78d9f
7 N5635f0cb7b884cf19e0e7546cecbe86f
8 N5e062667c8124bb0bde26ac1cd012f17
9 N63b37e2133d54684bcf4a646cc207b7a
10 N6527327f91004b4fa009b6dfbc2c6124
11 N7059d81fb4824e23baef57ff4a4ac6b0
12 N7caec069267d45a58dfd118d04346a03
13 N7cd54f5f4e5c456f829d63e27e77c8d3
14 N7dfa29657ec942a595138d0d011234eb
15 N836a657f0b054f968a69e6125d0d5c33
16 Nb322ad45b06e4542b0e1e3f576e1d514
17 Nb3e83b45e5cc4091b296bb1084b2aacd
18 Nc978fca49a344e9180b053ec0d515b3e
19 Nd15987c100e049479d91ab85f5edffcb
20 Ne68e31a8de454bb39aeec4b897b29481
21 Ne82f6c0a7f4a4620a060609676a4b733
22 Nf4084edda59d453bb1a6797553ade629
23 Nfd78dad894e84c32a66ecb099cf2d2a4
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author Nfbe29c243feb488da18dfb7e014a4bc5
27 schema:citation sg:pub.10.1007/bf01575124
28 sg:pub.10.1007/bf01967060
29 sg:pub.10.1007/bf02112616
30 sg:pub.10.1038/sj.bmt.1701406
31 sg:pub.10.1038/sj.bmt.1701543
32 sg:pub.10.1038/sj.bmt.1701630
33 schema:datePublished 2000-04-01
34 schema:datePublishedReg 2000-04-01
35 schema:description We conducted an open label, randomised clinical trial to compare amphotericin B colloidal dispersion (ABCD, Amphocil) 2 mg/kg/day intravenously with fluconazole 200 mg/day orally, for the prevention of fungal disease in neutropenic patients with haematological malignancies. In the event of unresolved fever after 4 days of empirical antibacterial therapy, patients in both treatment groups were to receive ABCD, 4 mg/kg/day. However, the study had to be stopped in an early phase, due to severe side-effects of ABCD. A total of 24 patients were enrolled, 12 patients were randomly assigned to receive prophylactic ABCD, which was administered for a mean of 13.9 days. Fluconazole prophylaxis was given to 12 patients for a mean of 21.2 days. Therapeutic ABCD, 4 mg/kg, was initiated in four patients because of suspected fungal infection, all of whom had initially received fluconazole. A high rate of infusion-related toxicity of ABCD was observed. Chills occurred in 15/16 ABCD recipients (94%), accompanied by a temperature rise of ⩾2°C in 4/16 patients and of ⩾1°C but <2°c in 10/16 patients. Other abcd-related adverse events were hypotension (4/16), nausea with vomiting (5/16), tachycardia (7/16), headache (3/16) and dyspnoea (3/16). For premedication patients received: antihistamines (12/16), hydrocortisone (9/16) and/or morphine (6/16). ABCD was discontinued in 8/16 patients (50%) due to side-effects, which ultimately dictated early termination of the study. we conclude that ABCD is not suitable for antifungal prophylaxis in neutropenic patients due to severe infusion-related side-effects. Subject numbers were too low for conclusions on variables of antifungal efficacy. Bone Marrow Transplantation(2000) 25 , 879–884.
36 schema:genre article
37 schema:isAccessibleForFree false
38 schema:isPartOf N13631f2b02454d88abacd1be9e1f43a5
39 N43d5be5725b74f8aab3aecba0815b43c
40 sg:journal.1096890
41 schema:keywords ABCD
42 adverse events
43 amphotericin B colloidal dispersion
44 antibacterial therapy
45 antifungal efficacy
46 antifungal prophylaxis
47 antihistamines
48 bone marrow
49 chills
50 clinical trials
51 colloidal dispersions
52 conclusion
53 data
54 days
55 disease
56 dispersion
57 early phase
58 early termination
59 efficacy
60 empirical antibacterial therapy
61 events
62 fever
63 fluconazole
64 fluconazole prophylaxis
65 fungal diseases
66 fungal infections
67 group
68 haematological malignancies
69 headache
70 high rate
71 hypotension
72 infection
73 infusion-related toxicity
74 labels
75 malignancy
76 marrow
77 means
78 morphine
79 nausea
80 neutropenic patients
81 number
82 open label
83 patients
84 phase
85 prevention
86 prophylaxis
87 rate
88 recipients
89 rise
90 study
91 subject numbers
92 tachycardia
93 temperature rise
94 termination
95 therapy
96 total
97 toxicity
98 treatment groups
99 trials
100 unresolved fever
101 variables
102 vomiting
103 schema:name Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial
104 schema:pagination 879-884
105 schema:productId N1e673b386f364d5895ad5896b06f1069
106 Ne1a369af366f48509a848aaab578187c
107 Nf899336f5581490288d44e88c0ba5307
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009839299
109 https://doi.org/10.1038/sj.bmt.1702243
110 schema:sdDatePublished 2022-09-02T15:49
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher N60b7515e228949b69aa509c2849e0f0d
113 schema:url https://doi.org/10.1038/sj.bmt.1702243
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N04964102cae44680b9ead4b7d1b24f50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Female
119 rdf:type schema:DefinedTerm
120 N08720ddbe11342d3a6c23026a631da1c rdf:first sg:person.0621051006.31
121 rdf:rest Nbb584579108b45ca9cde1ea20b985166
122 N13631f2b02454d88abacd1be9e1f43a5 schema:volumeNumber 25
123 rdf:type schema:PublicationVolume
124 N18335a9e5d9a48969e663cd07228dd61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Survival
126 rdf:type schema:DefinedTerm
127 N1e673b386f364d5895ad5896b06f1069 schema:name doi
128 schema:value 10.1038/sj.bmt.1702243
129 rdf:type schema:PropertyValue
130 N25401bfe614d4502b8d174d2908b0556 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Amphotericin B
132 rdf:type schema:DefinedTerm
133 N398d7edf3e7f445dbbe17725dacb676b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Morphine
135 rdf:type schema:DefinedTerm
136 N43d5be5725b74f8aab3aecba0815b43c schema:issueNumber 8
137 rdf:type schema:PublicationIssue
138 N45507437099340988e93bdbd04eb99ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Middle Aged
140 rdf:type schema:DefinedTerm
141 N53b5c127328946e4aea0978026f78d9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Bilirubin
143 rdf:type schema:DefinedTerm
144 N5635f0cb7b884cf19e0e7546cecbe86f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Fluconazole
146 rdf:type schema:DefinedTerm
147 N5e062667c8124bb0bde26ac1cd012f17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Shivering
149 rdf:type schema:DefinedTerm
150 N5fbc25fc6daa44b4beebe30fb0aab876 rdf:first sg:person.014426711334.33
151 rdf:rest N08720ddbe11342d3a6c23026a631da1c
152 N60b7515e228949b69aa509c2849e0f0d schema:name Springer Nature - SN SciGraph project
153 rdf:type schema:Organization
154 N63b37e2133d54684bcf4a646cc207b7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Hematologic Neoplasms
156 rdf:type schema:DefinedTerm
157 N6527327f91004b4fa009b6dfbc2c6124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Contraindications
159 rdf:type schema:DefinedTerm
160 N7059d81fb4824e23baef57ff4a4ac6b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Male
162 rdf:type schema:DefinedTerm
163 N73b31d8936d8420b91bed40d5f937a70 rdf:first sg:person.0643774744.24
164 rdf:rest rdf:nil
165 N7caec069267d45a58dfd118d04346a03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged
167 rdf:type schema:DefinedTerm
168 N7cd54f5f4e5c456f829d63e27e77c8d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Neutropenia
170 rdf:type schema:DefinedTerm
171 N7dfa29657ec942a595138d0d011234eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Consumer Product Safety
173 rdf:type schema:DefinedTerm
174 N836a657f0b054f968a69e6125d0d5c33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Infusions, Intravenous
176 rdf:type schema:DefinedTerm
177 Nb322ad45b06e4542b0e1e3f576e1d514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Hematopoietic Stem Cell Transplantation
179 rdf:type schema:DefinedTerm
180 Nb3e83b45e5cc4091b296bb1084b2aacd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Humans
182 rdf:type schema:DefinedTerm
183 Nbb584579108b45ca9cde1ea20b985166 rdf:first sg:person.07531170642.06
184 rdf:rest N73b31d8936d8420b91bed40d5f937a70
185 Nc978fca49a344e9180b053ec0d515b3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Mycoses
187 rdf:type schema:DefinedTerm
188 Nd15987c100e049479d91ab85f5edffcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Adolescent
190 rdf:type schema:DefinedTerm
191 Ne1a369af366f48509a848aaab578187c schema:name dimensions_id
192 schema:value pub.1009839299
193 rdf:type schema:PropertyValue
194 Ne68e31a8de454bb39aeec4b897b29481 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Transaminases
196 rdf:type schema:DefinedTerm
197 Ne82f6c0a7f4a4620a060609676a4b733 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Adult
199 rdf:type schema:DefinedTerm
200 Nf4084edda59d453bb1a6797553ade629 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Time Factors
202 rdf:type schema:DefinedTerm
203 Nf899336f5581490288d44e88c0ba5307 schema:name pubmed_id
204 schema:value 10808210
205 rdf:type schema:PropertyValue
206 Nfbe29c243feb488da18dfb7e014a4bc5 rdf:first sg:person.016464171734.29
207 rdf:rest Nfd26a83617cc475fa428f3dcd317fba7
208 Nfd26a83617cc475fa428f3dcd317fba7 rdf:first sg:person.01110171530.57
209 rdf:rest N5fbc25fc6daa44b4beebe30fb0aab876
210 Nfd78dad894e84c32a66ecb099cf2d2a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Respiratory Tract Diseases
212 rdf:type schema:DefinedTerm
213 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
214 schema:name Medical and Health Sciences
215 rdf:type schema:DefinedTerm
216 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
217 schema:name Clinical Sciences
218 rdf:type schema:DefinedTerm
219 sg:journal.1096890 schema:issn 0268-3369
220 1476-5365
221 schema:name Bone Marrow Transplantation
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01110171530.57 schema:affiliation grid-institutes:grid.16872.3a
225 schema:familyName Zweegman
226 schema:givenName S
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110171530.57
228 rdf:type schema:Person
229 sg:person.014426711334.33 schema:affiliation grid-institutes:grid.16872.3a
230 schema:familyName Simoons-Smit
231 schema:givenName AM
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014426711334.33
233 rdf:type schema:Person
234 sg:person.016464171734.29 schema:affiliation grid-institutes:grid.16872.3a
235 schema:familyName Timmers
236 schema:givenName GJ
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016464171734.29
238 rdf:type schema:Person
239 sg:person.0621051006.31 schema:affiliation grid-institutes:grid.16872.3a
240 schema:familyName van Loenen
241 schema:givenName AC
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621051006.31
243 rdf:type schema:Person
244 sg:person.0643774744.24 schema:affiliation grid-institutes:grid.16872.3a
245 schema:familyName Huijgens
246 schema:givenName PC
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643774744.24
248 rdf:type schema:Person
249 sg:person.07531170642.06 schema:affiliation grid-institutes:grid.16872.3a
250 schema:familyName Touw
251 schema:givenName D
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07531170642.06
253 rdf:type schema:Person
254 sg:pub.10.1007/bf01575124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046063617
255 https://doi.org/10.1007/bf01575124
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/bf01967060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001105921
258 https://doi.org/10.1007/bf01967060
259 rdf:type schema:CreativeWork
260 sg:pub.10.1007/bf02112616 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046675262
261 https://doi.org/10.1007/bf02112616
262 rdf:type schema:CreativeWork
263 sg:pub.10.1038/sj.bmt.1701406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022800093
264 https://doi.org/10.1038/sj.bmt.1701406
265 rdf:type schema:CreativeWork
266 sg:pub.10.1038/sj.bmt.1701543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024930306
267 https://doi.org/10.1038/sj.bmt.1701543
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/sj.bmt.1701630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024783933
270 https://doi.org/10.1038/sj.bmt.1701630
271 rdf:type schema:CreativeWork
272 grid-institutes:grid.16872.3a schema:alternateName Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
273 Department of Medical Microbiology and Infection Control, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
274 Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
275 schema:name Department of Haematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
276 Department of Medical Microbiology and Infection Control, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
277 Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...